A phase I/II trial of the safety and clinical activity of a HER2-protein based immunotherapeutic for treating women with HER2-positive metastatic breast cancer
Titel:
A phase I/II trial of the safety and clinical activity of a HER2-protein based immunotherapeutic for treating women with HER2-positive metastatic breast cancer
Auteur:
Curigliano, Giuseppe Romieu, Gilles Campone, Mario Dorval, Thierry Duck, Lionel Canon, Jean-Luc Roemer-Becuwe, Celia Roselli, Mario Neciosup, Silvia Burny, Wivine Callegaro, Andrea Sousa Alves, Pedro Miguel de Louahed, Jamila Brichard, Vincent Lehmann, Frédéric F.